2025上半年总票房达292.31亿元，同比增长22.91%。 综合各票房平台数据，截至7月2日，2025年暑期档（6月-8月）总票房（含预售）超20亿元，《碟中谍 8：最终清算》《酱园弄·悬案》《新·驯龙高手》《名侦探柯南：独眼的残像》《时间之子》暂列票房前 五名，并且档期票房均已破亿。 除了动画片之外，孙佳山认为历年暑期档的其他热门影片有一定的共性。他表示，从《战狼2》到《我 不是药神》再到《八角笼中》《孤注一掷》，暑期档已经充分验证了关切现实社会、反映现实焦虑的现 实题材影片是'引燃'暑期档的关键。他表示，今年暑期档丰富的内容布局，有望重现2023年《消失的 她》《八角笼中》《长安三万里》《封神第一部》《孤注一掷》等影片形成的接力式传播效应。 随着6月30日《哪吒2》在国内最后一天上映，今年的电影市场也正式进入"下半场"时间。值得一提的 是，刚过去的上半年是2020年以来全国票房表现最佳的上半年。 猫眼娱乐市场分析师赖力则对第一财经记者分析称，目前看来，暑期档进口片的整体表现要暂时好于国 产片。 对于动画电影领域，在中央文化和旅游管理干部学院研究员孙佳山看来，今年暑期档各类高质量动画电 影密集上映，折射 ...

围绕7月9日关税最后期限的博弈仍在持续。 距离美国政府所谓"对等关税"的90天暂停期到期只剩一周，尽管美国达成的贸易协议寥寥无几，但仍未 表示要延长这一最后期限。 据央视新闻报道，当地时间7月1日，美国总统特朗普称，未考虑推迟7月9日恢复加征关税的时间点。他 还表示"会给多国发信"通知将提高税率。 然而，目前美国与主要经济体的谈判进展仍不明朗。 本周四（7月3日），欧盟委员会贸易和经济安全委员谢夫乔维奇（Maroš Šefčovič）将与美方会谈磋 商。据报道，欧盟成员国要求，任何协议必须确保自7月9日起下调当前10%的关税，并进一步削减行业 性高关税。但美方则更倾向于采取类似英国的分阶段协议模式，并在后续谈判期间维持部分关税。 科多尼奥称，欧盟的策略是"为所有可能情况做好准备"，包括在必要时采取报复行动，"包括法国在内 的成员国姿态坚定并有针对性，对美国的反制措施可能会集中在有政治敏感性、可由欧洲企业替代以及 数字服务领域。" 为反制美国钢铝关税，欧盟已同意对价值210亿欧元的美国商品实施反制关税，除非双方达成协议，否 则这一反制措施将从7月14日自动生效。此外，欧盟正在讨论对价值高达950亿欧元的美国进口 ...

Investor Presentation NYSE: KEX May 2025 Forward Looking Statements Non-GAAP Financial Measures Statements contained in this presentation with respect to the future are forward-looking statements. These statements reflect management's reasonable judgment with respect to future events. Forward-looking statements involve risks and uncertainties. Actual results could differ materially from those anticipated as a result of various factors, including adverse economic conditions, industry competition and other co ...

新京报讯(记者张璐)记者从北京市科委、中关村管委会获悉，7月2日，微元合成生产的阿洛酮糖正式获 得国家卫生健康委员会新食品原料公告行政许可，微元合成成为全国首家获批在国内市场合法销售阿洛 酮糖的企业。此次批准的AS10菌株直接发酵法生产阿洛酮糖技术，是国内首个采用合成生物技术生产 的新食品原料获批的案例。 当前，微元合成位于秦皇岛的阿洛酮糖一期工厂已正式投产，二期工厂已启动，将于2027年投产。与此 同时，微元合成联合华北、东北、西北等地多家传统生物制造合作伙伴，正在抓紧推进多个十万吨级产 能改造项目，其中位于华北地区的6万吨级产能改造项目将于2025年10月投产，建成后将成为全球最大 的阿洛酮糖供应商。 像果葡糖浆一样，阿洛酮糖可以满足消费者对甜的需求，补充国内食糖的缺口，但不会带来身体代谢的 负担，同时对血糖控制和体重管理有积极作用。2024年12月，微元合成作为牵头单位申报的科技部国家 重点研发计划-颠覆性技术创新重点专项"低热量健康型阿洛酮糖绿色生物制造技术项目"获得批准立 项。微元合成通过自研生物计算AI平台，得到一步发酵生产菌AS10，AS10不仅是一个菌株，更是一个 可无限自主复制的"智能细胞工 ...

Core Viewpoint - Alibaba's stock has shown minimal appreciation since its IPO in 2014, currently trading at approximately 1.7 times its initial offering price of $68 per share [1]. Group 1: Investment Philosophy - The investment approach is long-term and value-focused, emphasizing fundamentals such as free cash flow, capital allocation, and downside protection [1]. - The investment strategy is inspired by renowned investors like Warren Buffett and Charlie Munger, focusing on businesses with durable economics and disciplined leadership [1]. - The goal is to understand how a company generates profit, identify risks, and evaluate management's decision-making track record [1]. Group 2: Research and Analysis - The company aims to share clear investment ideas and highlight overlooked opportunities that merit attention [1].

对于优酷体育而言，拿下苏超直播权不仅是顺应流量的听劝之举，更是完善体育内容生态的有益补充。 在体育领域，具备更优成绩或运动表现的运动队和运动员通常更受商业赞助的青睐。然而，这一规律在苏超来说似乎不太适用。 在苏超联赛输得连队名都"显示不全"的川队收获淘宝闪购送上的"丨臂之力"，所剩无几的笔画瞬间因为一个"臂"字充值了17笔。不过，川队下一轮的对手 徐州队丝毫不怂，凭借苏C的车牌代码，徐州得到"选C准没错"的支付宝冠名赞助。支付宝更是在微博向淘宝公开"叫板"："7月20日，你给我小心点！" 更离谱的是，无锡队就因为"无息"的谐音梗，拿下了花呗的赞助。网友直接发话："可以请梅西（没息）当代言人了。"5G网速的花呗也在微博@淘宝和支 付宝："你们要这么唠我可就不困了！"三家直接网上对线，网友直言：到了苏超，连阿里也成散装的了！而随着余额宝正式官宣成为扬州队的官方"攒"助 商，阿里系赞助的球队刚好凑成一桌！ 当然，玩笑归玩笑，来自阿里系的四大品牌集体赞助苏超球队，看中的主要是苏超如今非凡的破圈流量和高关注度。甚至网友们开始呼吁，天猫、饿了 么、菜鸟、夸克等其他阿里系品牌也可以加入到苏超的赞助序列当中。 气氛都烘托到这 ...

图片来源：Pixabay 6月28日，深交所公告称，因保荐人国联民生证券撤回发行上市申请，深交所决定终止开源证券发行上市审核。 2022年7月，开源证券向证监会提交深市主板的IPO申请并预披露招股说明书。2023年3月，深交所受理其IPO申请，次月，深交所向其发出第1轮 审核问询函，但截至目前，开源证券尚未披露问询函的回复。 值得一提的是，自受理以来，开源证券除持续更新招股书外，并没有实质性进展。也就说，从2022年7月至今，开源证券已经排队审核3年左右。 有媒体报道称，开源证券撤回申报材料与更换会计师事务所有关，主要因为国有企业连续聘任同一会计师事务所原则上不能超过8年。开源证券可 能会在2026年择机申报IPO。 更换会计事务所可能只是考虑因素之一，更重要的是，开源证券的业务面临着一定的风险。2024年开源证券收入28.59亿元，同比减少6.61%；净 利润6.95亿元，同比增长12.78%，增利不增收。还因存在违规多项违规行为，被暂停债券承销业务半年。2025年3月，其大连分公司也因违规，被 暂停部分业务半年。 01 依赖陕西市场 资料显示，开源证券总部位于陕西西安，控股股东为陕西煤业化工集团有限责任公 ...

Core Viewpoint - GDS Holdings Limited has successfully priced its China REIT (C-REIT) IPO at RMB 3.00 per unit, with significant oversubscription and substantial gross proceeds expected from the offering [1][2]. Group 1: IPO Details - The C-REIT's final offering price was determined after an institutional bookbuilding process that was 166 times oversubscribed [1]. - A total of 800,000,000 units will be issued, resulting in gross proceeds of RMB 2,400 million [1]. Group 2: Financial Metrics - At the final offering price, the implied EV/EBITDA is 16.9 times based on projected EBITDA for 2026 of RMB 141.8 million [2]. - The implied dividend yield per unit is 5.2% based on projected cash flow available for distribution for 2026 of RMB 124.8 million [2]. Group 3: Transaction and Cash Flow - GDS will sell a 100% equity interest in a project company holding stabilized data center assets for an enterprise value of approximately RMB 2,319 million [3]. - Upon completion of the sale, GDS will receive net cash proceeds of approximately RMB 2,111 million and de-consolidate about RMB 62 million of net debt [3]. - GDS plans to reinvest RMB 480 million to acquire 20% of the units issued by the C-REIT in the IPO [3]. Group 4: Operational Agreement - GDS will continue to manage the underlying data center assets under a services agreement, earning approximately RMB 5 million in recurring annual fee income [4]. Group 5: Company Overview - GDS Holdings Limited is a leading developer and operator of high-performance data centers in China, strategically located in major economic hubs [5]. - The company offers a range of services including co-location, managed hybrid cloud services, and has a diverse customer base including hyperscale cloud service providers and large corporations [5].

Company Overview - Hut 8 is an energy infrastructure platform integrating power, digital infrastructure, and compute at scale[10] - The company manages 1,020 MW of power generation capacity[12, 13] - Hut 8's Q1 2025 revenue was $21.8 million across its segments[13] Business Segments - Power segment revenue was $4.4 million in Q1 2025[13] - Digital Infrastructure segment revenue was $1.3 million in Q1 2025[13] - Compute segment revenue, including Bitcoin mining, was $16.1 million in Q1 2025[13] Strategic Initiatives - Hut 8 has a development pipeline of approximately 10.8 GW of capacity as of March 31, 2025[29, 31] - The company aims to increase its self-mining hashrate to approximately 25.0 EH/s with a fleet efficiency of 16.3 J/TH if it executes its purchase option with BITMAIN[30] - Hut 8 held 10,171 Bitcoin in reserve as of December 31, 2024[35] Financial Performance - The company's operating loss for Q1 2025 was $147.65 million[51, 52] - Net loss for Q1 2025 was $134.319 million[51, 52] - Adjusted EBITDA for Q1 2025 was $(117.696) million[51, 54]

Company Overview - SeaStar Medical is a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure[5] - The company's SCD therapy targets the upstream source of effector cells and neutralizes effector cells that release cytokines[28] - The SCD conveniently connects with existing continuous kidney renal therapy that is widely available in U S ICUs today[36] Clinical Data and Approvals - QUELIMMUNE is approved by the FDA as a Humanitarian Use Device (HUD) to treat pediatric patients with acute kidney injury and sepsis or septic condition weighing 10 kilograms and requiring kidney replacement therapy[22] - QUELIMMUNE clinical data in pediatric acute kidney injury shows a 77% survival rate at Day 60 compared to 50% with standard of care[42] - In adult AKI studies, 87.5% of pediatric patients had normal kidney function at Day 60[45] Market Opportunity - The total US annual market opportunity for the Adult AKI market is ~$4.5 billion, which is 50 times the size of the Pediatric AKI market (~$100 million)[24] - The adult acute kidney injury population is 50x larger than the pediatric population[18] Financials - As of May 14, 2025, the company has a market capitalization of $13.5 million[69]